We serve Chemical Name:Poly[1,2-bis(ethylthio)acetylene] CAS:93975-08-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Poly[1,2-bis(ethylthio)acetylene]
CAS.NO:93975-08-7
Synonyms:MFCD00241417
Molecular Formula:[C(SC2H5)=C(SC2H5)]n
Molecular Weight:N/A
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like MFCD00241417 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00241417 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00241417 Use and application,MFCD00241417 technical grade,usp/ep/jp grade.
Related News: A major advantage of identifying suitable biocatalysts early on is that it provides ample opportunity for optimization. tert-butyl 6-formyl-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-2-carboxylate manufacturers Soliris, first approved for generalized myasthenia gravis (gMG) in 2017, carries a list price of about $470,000 annually. But to ICER, that cost is “well beyond typical thresholds.” 3-[(2,6-dichlorophenyl)methyl]pentane-2,4-dione suppliers TULIP-2 assessed the effect of anifrolumab in reducing disease activity as measured by the BILAG-Based Composite Lupus Assessment (BICLA) scale. In TULIP-1, 457 eligible patients were randomised (1:2:2) and received a fixed-dose intravenous infusion of 150mg anifrolumab, 300mg anifrolumab or placebo every four weeks, 5,6,7,8-Tetrahydro-8-Isoquinolinamine vendor & factory.